Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 211

1.

The ups and downs of BDNF in Rett syndrome.

Sun YE, Wu H.

Neuron. 2006 Feb 2;49(3):321-3. Review.

PMID:
16446133
[PubMed - indexed for MEDLINE]
Free Article
2.

The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.

Chang Q, Khare G, Dani V, Nelson S, Jaenisch R.

Neuron. 2006 Feb 2;49(3):341-8.

PMID:
16446138
[PubMed - indexed for MEDLINE]
Free Article
3.

The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome.

Nectoux J, Bahi-Buisson N, Guellec I, Coste J, De Roux N, Rosas H, Tardieu M, Chelly J, Bienvenu T.

Neurology. 2008 May 27;70(22 Pt 2):2145-51. doi: 10.1212/01.wnl.0000304086.75913.b2. Epub 2008 Apr 23.

PMID:
18434641
[PubMed - indexed for MEDLINE]
4.

MeCP2 dysfunction in Rett syndrome and related disorders.

Moretti P, Zoghbi HY.

Curr Opin Genet Dev. 2006 Jun;16(3):276-81. Epub 2006 May 2. Review.

PMID:
16647848
[PubMed - indexed for MEDLINE]
5.

Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression.

Kondo M, Gray LJ, Pelka GJ, Christodoulou J, Tam PP, Hannan AJ.

Eur J Neurosci. 2008 Jun;27(12):3342-50. doi: 10.1111/j.1460-9568.2008.06305.x. Epub 2008 Jun 14.

PMID:
18557922
[PubMed - indexed for MEDLINE]
6.

MeCP2 in Rett syndrome: transcriptional repressor or chromatin architectural protein?

Chadwick LH, Wade PA.

Curr Opin Genet Dev. 2007 Apr;17(2):121-5. Epub 2007 Feb 20. Review.

PMID:
17317146
[PubMed - indexed for MEDLINE]
7.

Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.

Itoh M, Ide S, Takashima S, Kudo S, Nomura Y, Segawa M, Kubota T, Mori H, Tanaka S, Horie H, Tanabe Y, Goto Y.

J Neuropathol Exp Neurol. 2007 Feb;66(2):117-23.

PMID:
17278996
[PubMed - indexed for MEDLINE]
8.

Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.

Ben-Zeev B, Aharoni R, Nissenkorn A, Arnon R.

Med Hypotheses. 2011 Feb;76(2):190-3. doi: 10.1016/j.mehy.2010.09.015. Epub 2010 Oct 15.

PMID:
20951500
[PubMed - indexed for MEDLINE]
9.

MeCP2 deficiency in the brain decreases BDNF levels by REST/CoREST-mediated repression and increases TRKB production.

Abuhatzira L, Makedonski K, Kaufman Y, Razin A, Shemer R.

Epigenetics. 2007 Oct-Dec;2(4):214-22. Epub 2007 Oct 29.

PMID:
18075316
[PubMed - indexed for MEDLINE]
Free Article
10.

Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome.

Ogier M, Wang H, Hong E, Wang Q, Greenberg ME, Katz DM.

J Neurosci. 2007 Oct 3;27(40):10912-7.

PMID:
17913925
[PubMed - indexed for MEDLINE]
Free Article
11.

MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.

Kaufmann WE, Johnston MV, Blue ME.

Brain Dev. 2005 Nov;27 Suppl 1:S77-S87. Epub 2005 Sep 22. Review.

PMID:
16182491
[PubMed - indexed for MEDLINE]
12.

The story of Rett syndrome: from clinic to neurobiology.

Chahrour M, Zoghbi HY.

Neuron. 2007 Nov 8;56(3):422-37. Review.

PMID:
17988628
[PubMed - indexed for MEDLINE]
Free Article
13.

Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients.

Lilja T, Wallenborg K, Björkman K, Albåge M, Eriksson M, Lagercrantz H, Rohdin M, Hermanson O.

Epigenetics. 2013 Mar;8(3):246-51. doi: 10.4161/epi.23752. Epub 2013 Jan 24.

PMID:
23348913
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Mechanisms of disease: neurogenetics of MeCP2 deficiency.

Francke U.

Nat Clin Pract Neurol. 2006 Apr;2(4):212-21. Review.

PMID:
16932552
[PubMed - indexed for MEDLINE]
15.

Cognitive and social functions and growth factors in a mouse model of Rett syndrome.

Schaevitz LR, Moriuchi JM, Nag N, Mellot TJ, Berger-Sweeney J.

Physiol Behav. 2010 Jun 1;100(3):255-63. doi: 10.1016/j.physbeh.2009.12.025. Epub 2010 Jan 5.

PMID:
20045424
[PubMed - indexed for MEDLINE]
16.

Clinical profiles of four patients with Rett syndrome carrying a novel exon 1 mutation or genomic rearrangement in the MECP2 gene.

Bartholdi D, Klein A, Weissert M, Koenig N, Baumer A, Boltshauser E, Schinzel A, Berger W, Mátyás G.

Clin Genet. 2006 Apr;69(4):319-26.

PMID:
16630165
[PubMed - indexed for MEDLINE]
17.

RNAi-induced down-regulation of Mecp2 expression in the rat brain.

Jin J, Bao X, Wang H, Pan H, Zhang Y, Wu X.

Int J Dev Neurosci. 2008 Aug;26(5):457-65. doi: 10.1016/j.ijdevneu.2008.02.009. Epub 2008 Mar 4.

PMID:
18396005
[PubMed - indexed for MEDLINE]
18.

Rett syndrome: from the gene to the disease.

Matijevic T, Knezevic J, Slavica M, Pavelic J.

Eur Neurol. 2009;61(1):3-10. doi: 10.1159/000165342. Epub 2008 Oct 24. Review.

PMID:
18948693
[PubMed - indexed for MEDLINE]
19.

Epilepsy in Rett syndrome---the experience of a National Rett Center.

Nissenkorn A, Gak E, Vecsler M, Reznik H, Menascu S, Ben Zeev B.

Epilepsia. 2010 Jul;51(7):1252-8. doi: 10.1111/j.1528-1167.2010.02597.x. Epub 2010 May 13.

PMID:
20491871
[PubMed - indexed for MEDLINE]
20.

Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome.

Asaka Y, Jugloff DG, Zhang L, Eubanks JH, Fitzsimonds RM.

Neurobiol Dis. 2006 Jan;21(1):217-27. Epub 2005 Aug 8.

PMID:
16087343
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk